-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Imax, Raises Price Target to $47

Benzinga·12/08/2025 12:53:28
Listen to the news
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $42 to $47.